{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:10:31Z","timestamp":1790831431575,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":44,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["2009-4451"],"award-info":[{"award-number":["2009-4451"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jneuroim.2018.11.003","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T02:06:19Z","timestamp":1541642779000},"page":"14-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders"],"prefix":"10.1016","volume":"326","author":[{"given":"Paul","family":"Maddison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Titulaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gozzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh R.","family":"Irani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Graus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.11.003_bb0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.1139","article-title":"Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement","volume":"24","author":"AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2008.11.047","article-title":"Expression of Sox1, Sox2 and Sox9 is maintained in adult human cerebellar cortex","volume":"450","author":"Alcock","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jns.2016.09.002","article-title":"Prevalence of anti-SOX1 reactivity in various neurological disorders","volume":"369","author":"Berger","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/annonc\/mdq361","article-title":"Clinical validation of an autoantibody test for lung cancer","volume":"22","author":"Boyle","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0035","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-10-1363","article-title":"Autoantibodies in small cell lung cancer provide an opportunity for early detection","volume":"17","author":"Chapman","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10238-010-0127-0","article-title":"SOX2 gene expression in normal human thymus and thymoma","volume":"11","author":"Cimpean","year":"2011","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archneurol.2009.341","article-title":"Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers","volume":"67","author":"Giometto","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jnnp.2010.224105","article-title":"Which antibody and which cancer in which paraneoplastic syndromes?","volume":"10","author":"Gozzard","year":"2010","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0060","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123","author":"Gultekin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0075","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1073\/pnas.97.8.4198","article-title":"Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer","volume":"97","author":"G\u00fcre","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/mds.22129","article-title":"Cerebellar ataxia as a possible organ-specific autoimmune disease","volume":"23","author":"Hadjivassiliou","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0085","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/dvdy.21218","article-title":"Back to basics: Sox genes","volume":"236","author":"Kiefer","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0090","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/onc.2011.338","article-title":"Sox2 expression in breast tumours and activation in breast cancer stem cells","volume":"31","author":"Leis","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0095","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2407-11-42","article-title":"Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma","volume":"11","author":"Lengerke","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0100","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/modpathol.2015.116","article-title":"Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases","volume":"28","author":"Liang","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.lungcan.2010.03.002","article-title":"Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer","volume":"70","author":"Maddison","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0110","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/ijms12010410","article-title":"Exploring the immunoproteome for ovarian cancer biomarker discovery","volume":"12","author":"Martin","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0115","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/annonc\/mdp606","article-title":"Technical validation of an autoantibody test for lung cancer","volume":"21","author":"Murray","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0120","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1309\/AJCP7MNCNBCRN8NO","article-title":"Differential expression of SOX2 and SOX17 in testicular germ cell tumors","volume":"131","author":"Nonaka","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.20389","article-title":"Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome","volume":"32","author":"Oh","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0130","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0135","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.3800793","article-title":"Expression of Sox2 in mature and immature teratomas of central nervous system","volume":"20","author":"Phi","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0140","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0145","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060438","article-title":"Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer","volume":"8","author":"Sabater","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1586\/14737140.6.8.1215","article-title":"Use of autoantibodies in breast cancer screening and diagnosis","volume":"6","author":"Storr","year":"2006","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0160","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0165","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","article-title":"Screening for tumours in paraneoplastic syndromes: report of an EFNS task force","volume":"18","author":"Titulaer","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2010.07.005","article-title":"Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy","volume":"226","author":"Tschernatsch","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0185","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/cncr.21088","article-title":"Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters","volume":"103","author":"Vural","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00432-010-0867-y","article-title":"Expression of Sox2 in human ovarian epithelial carcinoma","volume":"137","author":"Ye","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2018.11.003_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/jcb.22054","article-title":"The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used","volume":"106","author":"Zuk","year":"2009","journal-title":"J. Cell. Biochem."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818304211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:13:03Z","timestamp":1790453583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818304211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"alternative-id":["S0165572818304211"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.003","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}